Avidity Biosciences, Inc (RNAM) — Cash Flow Reinvestment Rate

Latest as of December 2023: 0.05x

Avidity Biosciences, Inc (RNAM) has a Cash Flow Reinvestment Rate of 0.05x as of December 2023, reinvesting $863.00K (capex $863.00K ) from operating cash flow of $16.50 Million. Explore RNAM capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.05x
(Capex + Investments) / Operating CF

Total Reinvested

$863.00K
Capex + Investments

Operating Cash Flow

$16.50 Million
USD

Capital Expenditures

$863.00K
USD

Avidity Biosciences, Inc Cash Flow Reinvestment Rate (2019–2019)

Historical reinvestment intensity for Avidity Biosciences, Inc across 1 annual periods. Also explore Avidity Biosciences, Inc balance sheet assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Avidity Biosciences, Inc (2019–2019)

Year-by-year capital reinvestment analysis for Avidity Biosciences, Inc. For live market cap and broader valuation context, see Avidity Biosciences, Inc market cap and net worth.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2019 0.09x $235.00K $2.49 Million $235.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow